ACRI Students Group Discussion

Students of ACRI participate in group discussion on various topics.

Great News from ACRI India Placement Division

75% of previous batch students have been placed, with highest pay package of 4.5 and 4.0 Lakh PA respectively. Moreover the entire 75% candidates are placed in tier 1, MNC companies only. 25% of the students have been offered more than 4 Interview chances and they are still being assisted. 55% of the current batch has been placed even before the course completion.
http://acriindia.com/placement-reviews/student-reviews

ACRI INDIA Clinical Research Placement news

ACRI Placement is proud to announce that it has already placed up to 50% of its June 2013 students. 
http://acriindia.com/placement-reviews/placement-tieups

ACRI Workshop in news paper

News paper coverage about ACRI India Clinical Research Institute's workshop on 14th September 2013. 

http://acriindia.com

ACRI INDIA Clinical Research Workshop on Advances in Clinical Research and Pharmacovigilance

ACRI India Clinical Research Institute hosts a day-long workshop to educate medical professionals and students on recent advances in Clinical Research and Pharmacovigilance

Bangalore, 14^th September 2013: Bangalore-based ACRI India Clinical Research Institute, today conducted a day-long workshop on “Advances in Clinical Trials and Pharmacovigilance” for medical professionals and students from allied health science and life science. The workshop was inaugurated by  Ms Anuradha Ramachandran, Director, ACRI.

The idea to conduct this workshop was conceived to provide the latest trends seen in clinical research and Pharmacovigilance. The workshop witnessed overwhelming participants which in turn reflects the growing interest among doctors and life science graduates in choosing Clinical Research as new career arena.

The day-long workshop was divided into two sessions chaired by Dr Smita Singh, Head of Academics, ACRI and Dr Nisha Nair, an Industry Expert in PV. The first session was mentored by Dr Singh who took the participants on a tour of clinical research by capturing the various steps involved in a drug development in a presentation. Participants were provided with an introduction to Clinical research, followed by drug discovery procedures, good clinical practices and regulatory requirements for drug approval.

At the second session, Dr Nair focused on the current Indian Pharmacovigilance system, importance of Pharmacovigilance in clinical research and advancement required to gain World-wide credit. The session also highlighted other fundamentals of Pharmacovigilance system, such as science of detection, assessment, understanding and prevention of adverse events, reporting systems for adverse events and narrative writing.

The workshop was successfully concluded by furnishing the participants instructive and informative nuances of clinical research. At the end, certificates were handed over to the participants confirming them as ‘GCP trained’ which enable participants to further apply for Clinical Research profiles in CROs ( Contract Research Organization) with the knowledge acquired during the workshop.

ACRI India Clinical Research: is modeled on the lines of some of the premier Clinical Research Institutes of India. We are dedicated and committed to provide excellent Clinical Research Professionals to the Clinical Research Industries. At ACRI, we offer job oriented courses viz., “PG Diploma in Clinical Research” “Clinical Data Management” & “Clinical SAS Programming”

For more information please visit www.acriindia.com or call us at +91 9741 600 499 

Most preferred online course

MOST PREFERRED ONLINE COURSE

ACRI's online course "PG Diploma in Investigator's Responibilities"  is the most preferred course among all the Doctors viz., MBBS, BDS, BAMS, BPT & BHMS.

We are the only institute providing online course for Investigator’s responsibility.

Market Research Estimates the Central Laboratory Market at $1.5 Billion

Today much of the clinical development of new drugs is outsourced by the pharmaceutical industry. This outsourcing is managed by hundreds of contract research organizations world-wide ranging from global industry leaders such as Covance to small two person niche companies. The proportion of the work outsourced continues to grow at a healthy double digit rate and today approaches 30% on average. Laboratory pathology analysis of blood, urine and other patient specimens is on the other hand, outsourced at a virtually 100% level with few parameters, usually biomarkers, being analyzed in the pharmaceutical companies' laboratories.

The central laboratory business is by its very nature a global business now that the pharmaceutical industry has moved to global drug development. Unlike contract research organizations a small pathology laboratory cannot compete and the vast majority of the business is concentrated in the hands of relatively few, perhaps 20, large players.

Choosing a central laboratory and then contracting with it are vital to the successful outcome of a clinical trial

Selecting Preferred Providers.

While choosing a laboratory to conduct a specific study, following points should be kept in mind:

•  Favorable pricing and better service.
•  Quality assurance & Quality control.
•  Data Management.
• Single lab for all studies.
• Financial Stabilit.
• A Dedicated tea.
• Technical expertise and experience Support the launch of a test

Defining Expectations

Once a central laboratory has been selected, the success of the relationship will be largely determined before the first sample is delivered. It is important to define performance expectations at the outset of the relationship through mutual planning. Periodic meetings between the sponsor and laboratory provide opportunities for addressing measurements and discussing areas for improvement across all ongoing studies.

Here are some examples of expectations that could be set before the first study begins:

Sponsors should provide all necessary information to their laboratory four to six weeks in advance, thereby giving the laboratory ample time to set up the study properly. The first three weeks of the setup process will largely determine how smoothly it runs. There is no surer way to compromise a study than to give your central laboratory a week to set it up. After a study has been set up, it is vitally important that the sponsor make few if any changes, since they can have a cascading effect on all aspects of the trial.

Data file setup, including formatting, must be determined, which typically requires the laboratory to develop and submit a dummy file showing how data for all patients and all visits will be presented. This often requires the laboratory to facilitate communication between a sponsor’s clinical and data management personnel. Data cleanliness is essentially the byproduct of continuous improvement. The ultimate objective being a clean set of data for database lock at the end of the study. If a study requires development of new methods, the sponsor should give the central laboratory sufficient advance notice. The process is usually time-consuming and cannot be completed in a month.

Typically laboratories require advance notice for replenishment; participating physicians cannot realistically expect quality kits containing all the necessary contents and paperwork to be consistently delivered in 24 hours.

  

Following are some of the examples of Central Lab

Covance

Clearstone/MDS

ICON

Lab Corp

Quest

PPD

Quintiles